Synsam AB (publ) (SYNSAM.ST)
SEK 46.3
(0.76%)
SEK 46.3
(0.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.03 Billion SEK | 0.21% |
| 2022 | 8.01 Billion SEK | 5.47% |
| 2021 | 7.6 Billion SEK | 4.75% |
| 2020 | 7.25 Billion SEK | 5.3% |
| 2019 | 6.89 Billion SEK | 7.4% |
| 2018 | 6.41 Billion SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 8.21 Billion SEK | -1.1% |
| 2024 Q1 | 8.3 Billion SEK | 3.37% |
| 2023 Q4 | 8.03 Billion SEK | -0.59% |
| 2023 Q2 | 8.27 Billion SEK | 0.43% |
| 2023 Q1 | 8.23 Billion SEK | 2.69% |
| 2023 Q3 | 8.08 Billion SEK | -2.25% |
| 2023 FY | 8.03 Billion SEK | 0.21% |
| 2022 Q4 | 8.01 Billion SEK | 0.78% |
| 2022 FY | 8.01 Billion SEK | 5.47% |
| 2022 Q3 | 7.95 Billion SEK | 1.91% |
| 2022 Q2 | 7.8 Billion SEK | -0.48% |
| 2022 Q1 | 7.84 Billion SEK | 3.2% |
| 2021 Q1 | 7.37 Billion SEK | 1.61% |
| 2021 Q4 | 7.6 Billion SEK | 1.22% |
| 2021 Q3 | 7.51 Billion SEK | 2.64% |
| 2021 Q2 | 7.31 Billion SEK | -0.77% |
| 2021 FY | 7.6 Billion SEK | 4.75% |
| 2020 FY | 7.25 Billion SEK | 5.3% |
| 2020 Q4 | 7.25 Billion SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2019 FY | 6.89 Billion SEK | 7.4% |
| 2018 FY | 6.41 Billion SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AddLife AB (publ) | 12.74 Billion SEK | 36.948% |
| Biotage AB (publ) | 4.93 Billion SEK | -62.969% |
| Bonesupport Holding AB (publ) | 688.81 Million SEK | -1066.64% |
| Doxa AB (publ) | 3.75 Billion SEK | -114.019% |
| Elekta AB (publ) | 31.41 Billion SEK | 74.418% |
| iZafe Group AB (publ) | 34.61 Million SEK | -23116.04% |
| Ortivus AB (publ) | 72.7 Million SEK | -10952.733% |
| Ortivus AB (publ) | 72.7 Million SEK | -10952.733% |
| Q-linea AB (publ) | 231.97 Million SEK | -3364.151% |
| S2Medical AB (publ) | 21.4 Million SEK | -37438.406% |